title: Absence of increased susceptibility of LDL to oxidation in type 1 diabetics.
abstract: Insulin-dependent diabetics have a greatly increased risk of developing premature coronary artery disease which is not entirely explained by known risk factors. A possible explanation may be enhanced oxidative modification of low density lipoprotein (LDL). The aim of this study was to determine firstly, whether or not LDL from moderately well controlled type 1 diabetics is more readily oxidisable than LDL from healthy non-diabetics and, secondly, to assess whether potential predictors of LDL oxidisability differ between type 1 diabetics and controls. Twenty type 1 diabetic men were carefully matched with healthy non-diabetic men on the basis of age and body mass index and each pair attended the department on the same morning for blood sampling. LDL oxidisability was assessed using both copper in PBS, 15 and 30 mM glucose, and with AAPH. There was no difference between type 1 diabetics and controls in the susceptibility of the LDL to either copper-dependent or non-transition metal-dependent oxidation. Furthermore, there was no difference between the groups for LDL vitamin E content, LDL fatty acid composition in cholesteryl esters, triglycerides or phospholipids, or LDL copper reductive capacity, but LDL glycation was elevated in the IDDM subjects. Given the absence of increased LDL oxidisability in these subjects, the recommendation of vitamin E supplementation in type 1 diabetics should be considered a secondary priority to achieving adequate glucose control.
authors.affiliation: Department of Medicine, University of Western Australia, Perth, Australia.
authors.forename: S F
authors.initials: SF
authors.lastname: O'Brien
authors.forename: T A
authors.initials: TA
authors.lastname: Mori
authors.forename: I B
authors.initials: IB
authors.lastname: Puddey
authors.forename: K G
authors.initials: KG
authors.lastname: Stanton
mesh_terms: D000328:Adult; D000578:Amidines / Q000378:metabolism / Q000494:pharmacology; D002788:Cholesterol Esters / Q000032:analysis; D003300:Copper / Q000378:metabolism / Q000494:pharmacology; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000378:metabolism* / Q000503:physiopathology; D005947:Glucose / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D015227:Lipid Peroxidation / Q000502:physiology*; D008077:Lipoproteins, LDL / Q000737:chemistry / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009994:Osmolar Concentration; D010084:Oxidation-Reduction; D010743:Phospholipids / Q000032:analysis; D012016:Reference Values; D017392:Thiobarbituric Acid Reactive Substances / Q000378:metabolism; D013997:Time Factors; D014280:Triglycerides / Q000032:analysis
chemical_list: D000578:Amidines; D002788:Cholesterol Esters; D008077:Lipoproteins, LDL; D010743:Phospholipids; D017392:Thiobarbituric Acid Reactive Substances; D014280:Triglycerides; C046728:2,2'-azobis(2-amidinopropane); D003300:Copper; D005947:Glucose